Atrial fibrillation (AF) and chronic kidney disease (CKD) are closely related conditions with
shared risk factors. The growing prevalence of both AF and CKD indicates that more patients …

The cardiorenal nexus encompasses a bidirectional relationship between the heart and the
kidneys. Chronic abnormalities in cardiac function can lead to progressive kidney disease …

Importance Patients with venous thromboembolism (VTE) and concomitant chronic kidney
disease (CKD) have been reported to have a higher risk of thrombosis and major bleeding …

The Global Anticoagulant Registry in the Field-Atrial Fibrillation (GARFIELD-AF) examined
real-world practice in a total of 57,149 (5069 retrospective, 52,080 prospective) patients with …

Atrial fibrillation (AF) and renal insufficiency often coexist and are increasingly prevalent with
advancing age. Both the risk of thromboembolic events and bleeding propensity are higher …

Background Treatment with vitamin K antagonists (VKAs) has been linked to worsening of
kidney function in patients with atrial fibrillation (AF). Objectives XARENO (Factor XA …

Aims Despite widely available risk stratification tools, safe and effective anticoagulant
options, and guideline recommendations, anticoagulation for stroke prevention in atrial …

Aim The aim of this study is to examine the association of the presence of chronic kidney
disease (CKD) and estimated glomerular filtration rate (eGFR) values with mortality in …

Background Advancing age, decreasing renal function, and atrial fibrillation are strongly
associated. Real-world evidence of direct oral anticoagulant (DOAC) use among elderly …

Background Reports suggest that renal decline is greater among patients with non-valvular
atrial fibrillation (NVAF) treated chronically with warfarin vs. some non-vitamin K antagonist …